Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Karyopharm Therapeutics Inc. (KPTI)  
$0.96 0.01 (1.31%) as of 4:30 Fri 6/7


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 113,340,000
Market Cap: 108.83(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6758 - $2.34
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Karyopharm Therapeutics is a pharmaceutical company focused on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Co.'s main asset, XPOVIO® (selinexor), a Selective Inhibitors of Nuclear Export compound, is indicated for use in adult patients with multiple myeloma who have received at least one prior therapy; adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 41,140 41,140
Total Buy Value $0 $0 $49,985 $49,985
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 924,350 1,173,939 1,216,699 1,560,865
Total Sell Value $901,474 $1,198,663 $1,255,793 $3,019,031
Total People Sold 4 7 7 8
Total Sell Transactions 8 26 36 61
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 620
  Page 7 of 25  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-15 4 OE $0.00 $0 D/D 21,800 584,621     -
   Shacham Sharon President & CSO   •       –      –    2021-02-15 4 OE $0.00 $0 I/I 21,800 584,621     -
   Shacham Sharon President & CSO   •       –      –    2021-02-15 4 OE $0.00 $0 D/D 21,800 785,947     -
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2021-02-15 4 OE $0.00 $0 D/D 4,850 52,977     -
   Lewis Tanya EVP, Chief Reg. Affairs   •       –      –    2021-02-11 4 S $15.52 $31,752 D/D (2,046) 4,143 33%     
   Frenkel Ran EVP, Chief Dev. Officer   •       –      –    2021-02-11 4 S $15.52 $31,752 D/D (2,046) 39,338 33%     
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-11 4 S $15.52 $103,077 I/I (6,642) 764,147 33%     
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-11 4 S $15.52 $102,441 D/D (6,601) 562,821 33%     
   Shacham Sharon President & CSO   •       –      –    2021-02-11 4 S $15.52 $102,441 I/I (6,601) 562,821 33%     
   Shacham Sharon President & CSO   •       –      –    2021-02-11 4 S $15.52 $103,077 D/D (6,642) 764,147 33%     
   Mason Michael SVP, CFO & Treasurer   •       –      –    2021-02-11 4 S $15.52 $44,354 D/D (2,858) 5,292 33%     
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2021-02-11 4 S $15.52 $27,127 D/D (1,748) 48,127 33%     
   Mason Michael SVP, CFO & Treasurer   •       –      –    2021-02-05 4 OE $0.00 $0 D/D 8,150 8,150     -
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2021-02-05 4 OE $0.00 $0 D/D 5,650 49,875     -
   Shacham Sharon President & CSO   •       –      –    2021-02-05 4 OE $0.00 $0 I/I 14,300 569,422     -
   Shacham Sharon President & CSO   •       –      –    2021-02-05 4 OE $0.00 $0 D/D 14,300 770,789     -
   Frenkel Ran EVP, Chief Dev. Officer   •       –      –    2021-02-05 4 OE $0.00 $0 D/D 5,650 41,384     -
   Lewis Tanya EVP, Chief Reg. Affairs   •       –      –    2021-02-05 4 OE $0.00 $0 D/D 5,650 6,189     -
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-05 4 OE $0.00 $0 I/I 14,300 770,789     -
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-05 4 OE $0.00 $0 D/D 14,300 569,422     -
   Mirza Mansoor Raza Director   –       •      –    2020-12-18 4 AS $18.00 $90,000 D/D (5,000) 0 -43%     
   Mirza Mansoor Raza Director   –       •      –    2020-12-18 4 OE $5.43 $27,150 D/D 5,000 5,000     -
   Mirza Mansoor Raza Director   –       •      –    2020-12-07 4 AS $16.04 $321,383 D/D (20,000) 0 -41%     
   Mirza Mansoor Raza Director   –       •      –    2020-12-07 4 OE $5.43 $108,600 D/D 20,000 20,000     -
   Primiano Christopher Brett EVP, CBO, GC & Secretary   •       –      –    2020-12-01 4 AS $17.35 $2,402,227 D/D (137,061) 4,523 -40%     
  620 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 25
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us